Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Change in Cash (2016 - 2025)

Plus Therapeutics has reported Change in Cash over the past 16 years, most recently at -$4.5 million for Q4 2025.

  • Quarterly Change in Cash fell 295.03% to -$4.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.7 million through Dec 2025, up 202.41% year-over-year, with the annual reading at $8.7 million for FY2025, 202.41% up from the prior year.
  • Change in Cash was -$4.5 million for Q4 2025 at Plus Therapeutics, down from $11.1 million in the prior quarter.
  • Over five years, Change in Cash peaked at $11.1 million in Q3 2025 and troughed at -$7.6 million in Q2 2025.
  • The 5-year median for Change in Cash is -$1.8 million (2023), against an average of -$208294.1.
  • Year-over-year, Change in Cash skyrocketed 498.5% in 2021 and then plummeted 3423.42% in 2024.
  • A 5-year view of Change in Cash shows it stood at $6.1 million in 2021, then tumbled by 135.17% to -$2.1 million in 2022, then fell by 14.26% to -$2.5 million in 2023, then skyrocketed by 53.22% to -$1.1 million in 2024, then plummeted by 295.03% to -$4.5 million in 2025.
  • Per Business Quant, the three most recent readings for PSTV's Change in Cash are -$4.5 million (Q4 2025), $11.1 million (Q3 2025), and -$7.6 million (Q2 2025).